Skip to main content
Top
Published in: Gut Pathogens 1/2023

Open Access 01-12-2023 | Vancomycin | Brief Report

Risk factors for gut colonization with vancomycin-resistant enterococci among Bulgarian critically ill patients

Authors: Preslava M. Hristova, Teodora V. Marinova-Bulgaranova, Tanya V. Strateva, Stefan V. Trifonov, Hristina Y. Hitkova

Published in: Gut Pathogens | Issue 1/2023

Login to get access

Abstract

Vancomycin-resistant enterococci (VRЕ) are recognized as important hospital pathogens which have become common in patients admitted to the intensive care units (ICUs). The purpose of this study was to evaluate the incidence of and the risk factors for colonization with VRE among ICU patients. A total of 91 patients who had duration of hospitalization more than 48 h and without infection caused by VRE or/and other microorganisms in the ICU at University Hospital, Pleven were screened for colonization with VRE. The following data were collected: demographic characteristics, clinical information and antimicrobials use. The statistical analysis was performed using SPSS version 27.0. Colonization with VRE was established in 22 patients and one was carrying two enterococcal species. A total of 23 VRE were isolated. The univariate analysis showed that the postoperative critical cares (p < 0.001), cardiovascular diseases (p = 0.009) and the presence of an endotracheal tube (p = 0.003) were risk factors for colonization with VRE. Also, the postoperative critical cares (p = 0.021) and cardiovascular diseases (p = 0.018) were confirmed as independent risk factor for VRE acquisition by multivariate analysis. The prevalence of VRE colonization among the ICU patients was relatively high (24.2%). Risk factors for acquisition of intestinal VRE were the postoperative cares, cardiovascular diseases and the presence of an endotracheal tube.
Literature
1.
go back to reference Sohn KM, Peck KR, Joo EJ, Ha YE, Kang CI, Chung DR, et al. Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital. Int J Infect Dis. 2013;17:e240–246.CrossRefPubMed Sohn KM, Peck KR, Joo EJ, Ha YE, Kang CI, Chung DR, et al. Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital. Int J Infect Dis. 2013;17:e240–246.CrossRefPubMed
2.
go back to reference Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother. 2003;51:iii13–21.CrossRefPubMed Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother. 2003;51:iii13–21.CrossRefPubMed
3.
go back to reference Monticelli J, Knezevich A, Luzzati R, Di Bella S. Clinical management of non-faecium non-faecalis vancomycin-resistant enterococci infection. Focus on Enterococcus gallinarum and Enterococcus casseliflavus/flavescens. J Infect Chemother. 2018;24(4):237–46.CrossRefPubMed Monticelli J, Knezevich A, Luzzati R, Di Bella S. Clinical management of non-faecium non-faecalis vancomycin-resistant enterococci infection. Focus on Enterococcus gallinarum and Enterococcus casseliflavus/flavescens. J Infect Chemother. 2018;24(4):237–46.CrossRefPubMed
4.
go back to reference Kara A, Devrim I, Bayram N, Katipoglu N, Kıran E, Oruc Y, et al. Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci. Braz J Infect Dis. 2015;19:58–61.CrossRefPubMed Kara A, Devrim I, Bayram N, Katipoglu N, Kıran E, Oruc Y, et al. Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci. Braz J Infect Dis. 2015;19:58–61.CrossRefPubMed
5.
go back to reference Hristova P, Nankov V, Stoikov I, Ivanov I, Ouzounova-Raykova V, Hitkova H. Prevalence of genes encoding resistance to aminoglycosides and virulence factors among intestinal vancomycin-resistant enterococci. Jundishapur J Microbiol. 2022;15:e128003.CrossRef Hristova P, Nankov V, Stoikov I, Ivanov I, Ouzounova-Raykova V, Hitkova H. Prevalence of genes encoding resistance to aminoglycosides and virulence factors among intestinal vancomycin-resistant enterococci. Jundishapur J Microbiol. 2022;15:e128003.CrossRef
6.
go back to reference Tresoldi AT, Cardoso LGO, Castilho GV, Dantas SRPE, von Nowakonski A, Pereira RM, et al. Low prevalence of vancomycin resistant enterococci colonization in intensive care patients in a brazilian teaching hospital. Braz J Infect Dis. 2006;10:239–41.CrossRefPubMed Tresoldi AT, Cardoso LGO, Castilho GV, Dantas SRPE, von Nowakonski A, Pereira RM, et al. Low prevalence of vancomycin resistant enterococci colonization in intensive care patients in a brazilian teaching hospital. Braz J Infect Dis. 2006;10:239–41.CrossRefPubMed
7.
go back to reference Batistao DWda, F, Gontijo-Filho PP, Conceição N, de Oliveira AG, Ribas RM. Risk factors for vancomycin-resistant enterococci colonisation in critically ill patients. Mem Inst Oswaldo Cruz. 2012;107:57–63.CrossRefPubMed Batistao DWda, F, Gontijo-Filho PP, Conceição N, de Oliveira AG, Ribas RM. Risk factors for vancomycin-resistant enterococci colonisation in critically ill patients. Mem Inst Oswaldo Cruz. 2012;107:57–63.CrossRefPubMed
8.
go back to reference Ziakas PD, Thapa R, Rice LB, Mylonakis E. Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies. PLoS ONE. 2013;8:e75658.CrossRefPubMedPubMedCentral Ziakas PD, Thapa R, Rice LB, Mylonakis E. Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies. PLoS ONE. 2013;8:e75658.CrossRefPubMedPubMedCentral
9.
go back to reference Furtado GHC, Martins ST, Coutinho AP, Wey SB, Medeiros EAS. Prevalence and factors associated with rectal vancomycin-resistant enterococci colonization in two intensive care units in Sao Paulo, Brazil. Braz J Infect Dis. 2005;9:64–9.CrossRefPubMed Furtado GHC, Martins ST, Coutinho AP, Wey SB, Medeiros EAS. Prevalence and factors associated with rectal vancomycin-resistant enterococci colonization in two intensive care units in Sao Paulo, Brazil. Braz J Infect Dis. 2005;9:64–9.CrossRefPubMed
10.
go back to reference Amberpet R, Sujatha Sistla SC, Parija. Molly Mary Thabah. Screening for intestinal colonization with vancomycin resistant enterococci and associated risk factors among patients admitted to an adult intensive care unit of a large teaching hospital. J Clin Diagnostic Res. 2016;10:DC06–9. Amberpet R, Sujatha Sistla SC, Parija. Molly Mary Thabah. Screening for intestinal colonization with vancomycin resistant enterococci and associated risk factors among patients admitted to an adult intensive care unit of a large teaching hospital. J Clin Diagnostic Res. 2016;10:DC06–9.
11.
go back to reference Duarte L, Arbo A, Gallardo M, Riquelme I, Delgadillo L, Jimenez HJ. Factors associated with vancomycin-resistant enterococci colonization in a pediatric intensive care unit of Paraguay: a cross-sectional study on hospital charts. Medwave. 2019;19:e7694–4.CrossRefPubMed Duarte L, Arbo A, Gallardo M, Riquelme I, Delgadillo L, Jimenez HJ. Factors associated with vancomycin-resistant enterococci colonization in a pediatric intensive care unit of Paraguay: a cross-sectional study on hospital charts. Medwave. 2019;19:e7694–4.CrossRefPubMed
12.
go back to reference Pan SC, Wang JT, Chen YC, Chang YY, Chen ML, Chang SC. Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit. PLoS ONE. 2012;7:e47297.CrossRefPubMedPubMedCentral Pan SC, Wang JT, Chen YC, Chang YY, Chen ML, Chang SC. Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit. PLoS ONE. 2012;7:e47297.CrossRefPubMedPubMedCentral
13.
go back to reference Yoon YK, Lee SE, Lee J, Kim HJ, Kim JY, Park DW, et al. Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study. J Antimicrob Chemother. 2011;66:1831–38.CrossRefPubMed Yoon YK, Lee SE, Lee J, Kim HJ, Kim JY, Park DW, et al. Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study. J Antimicrob Chemother. 2011;66:1831–38.CrossRefPubMed
Metadata
Title
Risk factors for gut colonization with vancomycin-resistant enterococci among Bulgarian critically ill patients
Authors
Preslava M. Hristova
Teodora V. Marinova-Bulgaranova
Tanya V. Strateva
Stefan V. Trifonov
Hristina Y. Hitkova
Publication date
01-12-2023
Publisher
BioMed Central
Keywords
Vancomycin
Care
Published in
Gut Pathogens / Issue 1/2023
Electronic ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-023-00564-x

Other articles of this Issue 1/2023

Gut Pathogens 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine